AlphaMark Advisors LLC Reduces Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
AlphaMark Advisors LLC lessened its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) by 3.2% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,685 shares of the biopharmaceutical company’s stock after selling 56 shares during the […]
More Stories
Endava (NYSE:DAVA) Updates FY 2025 Earnings Guidance
Endava (NYSE:DAVA – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
MillerKnoll (NASDAQ:MLKN) Updates FY 2025 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
UMB Financial Co. (NASDAQ:UMBF) Given Average Rating of “Buy” by Brokerages
Shares of UMB Financial Co. (NASDAQ:UMBF – Get Free Report) have earned an average rating of “Buy” from the six...
Brokerages Set Air Transport Services Group, Inc. (NASDAQ:ATSG) Price Target at $21.67
Air Transport Services Group, Inc. (NASDAQ:ATSG – Get Free Report) has received an average rating of “Moderate Buy” from the...
Mellstroy Net Worth: Controversies, Bans, and Scandals
Andrey Aleksandrovich Burim, known by his stage name, Mellstroy, is a European trash streamer. A controversial YouTuber, he gained popularity...
Lam Research Co. (NASDAQ:LRCX) Receives Average Recommendation of “Moderate Buy” from Brokerages
Lam Research Co. (NASDAQ:LRCX – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the nineteen brokerages...